Hemorrhagic cystitis associated with BKV in patients with refractory acute lymphoblastic leukemia.
Azzi
A
A
Ciappi
S
S
De Santis
R
R
Fanci
R
R
Leoni
F
F
Colli
S
S
Rossi-Ferrini
P L
PL
D000971:Antineoplastic Combined Chemotherapy Protocols; D001739:BK Virus; D003520:Cyclophosphamide / Q000009:adverse effects; D003556:Cystitis / Q000209:etiology* / Q000382:microbiology; D003561:Cytarabine / Q000009:adverse effects; D006470:Hemorrhage; D006801:Humans; D016867:Immunocompromised Host; D015080:Mesna / Q000627:therapeutic use; D030361:Papillomavirus Infections / Q000150:complications* / Q000276:immunology; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000150:complications* / Q000188:drug therapy; D011241:Prednisone / Q000009:adverse effects; D014412:Tumor Virus Infections / Q000150:complications*; D014750:Vincristine / Q000009:adverse effects
D003561:Cytarabine; D014750:Vincristine; D003520:Cyclophosphamide; D015080:Mesna; D011241:Prednisone